| 0 |
REACTIVE ANGIOENDOTHELIOMATOSIS |
1 |
0.3333 |
| 1 |
HYPOTHALAMIC OBESITY |
1 |
0.2500 |
| 2 |
LEPTIN LEVEL INCREASED |
1 |
0.0909 |
| 3 |
OROPHARYNGEAL COBBLE STONE MUCOSA |
1 |
0.0714 |
| 4 |
MALE GENITAL EXAMINATION ABNORMAL |
1 |
0.0435 |
| 5 |
ENDOMETRIAL HYPERPLASIA WITH CELLULAR ATYPIA |
1 |
0.0357 |
| 6 |
THYROID NODULE REMOVAL |
1 |
0.0250 |
| 7 |
OLFACTORY DYSFUNCTION |
1 |
0.0238 |
| 8 |
IRIS DISCOLOURATION |
1 |
0.0217 |
| 9 |
MELANODERMA |
4 |
0.0208 |
| 10 |
EPHELIDES |
10 |
0.0185 |
| 11 |
OPTIC DISC DRUSEN |
1 |
0.0159 |
| 12 |
EXERTIONAL HEADACHE |
1 |
0.0156 |
| 13 |
SPONTANEOUS PENILE ERECTION |
9 |
0.0145 |
| 14 |
DYSANIA |
1 |
0.0130 |
| 15 |
RAOULTELLA ORNITHINOLYTICA INFECTION |
1 |
0.0130 |
| 16 |
PIGMENTATION LIP |
1 |
0.0093 |
| 17 |
OPTIC DISC OEDEMA |
1 |
0.0086 |
| 18 |
CIRCUMCISION |
1 |
0.0071 |
| 19 |
TANNING |
1 |
0.0068 |
| 20 |
DIAPHRAGMATIC SPASM |
1 |
0.0068 |
| 21 |
FEAR-RELATED AVOIDANCE OF ACTIVITIES |
1 |
0.0066 |
| 22 |
UROBILINOGEN URINE INCREASED |
1 |
0.0061 |
| 23 |
DYSPLASTIC NAEVUS |
2 |
0.0055 |
| 24 |
BLOOD KETONE BODY PRESENT |
1 |
0.0053 |
| 25 |
BLOOD TEST |
1 |
0.0053 |
| 26 |
HERNIA HIATUS REPAIR |
1 |
0.0049 |
| 27 |
SKIN HYPERPIGMENTATION |
42 |
0.0049 |
| 28 |
INJECTION SITE PLAQUE |
1 |
0.0048 |
| 29 |
MELANOCYTIC NAEVUS |
20 |
0.0046 |
| 30 |
NAIL PIGMENTATION |
1 |
0.0041 |
| 31 |
DELAYED PUBERTY |
1 |
0.0039 |
| 32 |
DUMPING SYNDROME |
1 |
0.0038 |
| 33 |
OESOPHAGEAL FOOD IMPACTION |
2 |
0.0036 |
| 34 |
GENERALISED PUSTULAR PSORIASIS |
1 |
0.0034 |
| 35 |
INJECTION SITE HYPERTROPHY |
1 |
0.0031 |
| 36 |
CENTRAL HYPOTHYROIDISM |
1 |
0.0030 |
| 37 |
BENIGN NEOPLASM OF SKIN |
1 |
0.0030 |
| 38 |
DIAPHRAGMALGIA |
1 |
0.0029 |
| 39 |
MUSCLE HYPERTROPHY |
1 |
0.0028 |
| 40 |
FIBROUS HISTIOCYTOMA |
1 |
0.0028 |
| 41 |
EAR OPERATION |
1 |
0.0027 |
| 42 |
INTRACRANIAL TUMOUR HAEMORRHAGE |
1 |
0.0026 |
| 43 |
FAT TISSUE DECREASED |
1 |
0.0026 |
| 44 |
BONE DENSITY INCREASED |
1 |
0.0025 |
| 45 |
DRUG TITRATION ERROR |
6 |
0.0023 |
| 46 |
SARCOPENIA |
1 |
0.0023 |
| 47 |
HAEMANGIOMA OF SKIN |
1 |
0.0023 |
| 48 |
ADRENOCORTICOTROPIC HORMONE DEFICIENCY |
2 |
0.0023 |
| 49 |
REFUSAL OF TREATMENT BY RELATIVE |
1 |
0.0022 |
| 50 |
BODY HEIGHT INCREASED |
1 |
0.0020 |
| 51 |
WEIGHT LOSS POOR |
10 |
0.0020 |
| 52 |
HEART FAILURE WITH REDUCED EJECTION FRACTION |
1 |
0.0019 |
| 53 |
INTERTRIGO |
1 |
0.0018 |
| 54 |
BURNOUT SYNDROME |
1 |
0.0018 |
| 55 |
PRECOCIOUS PUBERTY |
1 |
0.0018 |
| 56 |
LIP DISCOLOURATION |
2 |
0.0016 |
| 57 |
ENDOMETRIAL ADENOCARCINOMA |
1 |
0.0016 |
| 58 |
THYROXINE FREE INCREASED |
1 |
0.0016 |
| 59 |
PAINFUL ERECTION |
1 |
0.0015 |
| 60 |
OPHTHALMIC MIGRAINE |
1 |
0.0014 |
| 61 |
FLUID IMBALANCE |
1 |
0.0014 |
| 62 |
OVARIAN MASS |
1 |
0.0014 |
| 63 |
PRECANCEROUS SKIN LESION |
2 |
0.0014 |
| 64 |
PHIMOSIS |
1 |
0.0014 |
| 65 |
SOFT TISSUE INJURY |
1 |
0.0013 |
| 66 |
SENSITISATION |
1 |
0.0013 |
| 67 |
PRODUCT INEFFECTIVE |
1 |
0.0013 |
| 68 |
CROUP INFECTIOUS |
1 |
0.0013 |
| 69 |
RETINAL PIGMENTATION |
1 |
0.0013 |
| 70 |
VITAMIN B12 INCREASED |
1 |
0.0013 |
| 71 |
DIABETES INSIPIDUS |
3 |
0.0012 |
| 72 |
SKIN BACTERIAL INFECTION |
1 |
0.0012 |
| 73 |
HAND-FOOT-AND-MOUTH DISEASE |
1 |
0.0012 |
| 74 |
TONSILLECTOMY |
2 |
0.0012 |
| 75 |
AMAUROSIS |
1 |
0.0012 |
| 76 |
SUPERFICIAL VEIN THROMBOSIS |
1 |
0.0012 |
| 77 |
SOLILOQUY |
1 |
0.0012 |
| 78 |
JAW OPERATION |
1 |
0.0011 |
| 79 |
FIBROMA |
1 |
0.0011 |
| 80 |
DISTURBANCE IN SEXUAL AROUSAL |
1 |
0.0011 |
| 81 |
SOLAR LENTIGO |
1 |
0.0011 |
| 82 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
2 |
0.0010 |
| 83 |
BINGE EATING |
1 |
0.0009 |
| 84 |
AORTIC DILATATION |
1 |
0.0009 |
| 85 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
2 |
0.0009 |
| 86 |
HUNGER |
12 |
0.0009 |
| 87 |
DEVICE DISPENSING ERROR |
1 |
0.0008 |
| 88 |
INJECTION SITE NODULE |
9 |
0.0008 |
| 89 |
STAPHYLOCOCCAL SKIN INFECTION |
1 |
0.0008 |
| 90 |
RENAL ATROPHY |
1 |
0.0008 |
| 91 |
BILIARY OBSTRUCTION |
1 |
0.0008 |
| 92 |
FEELINGS OF WORTHLESSNESS |
1 |
0.0008 |
| 93 |
FOOD CRAVING |
4 |
0.0008 |
| 94 |
FEELING GUILTY |
1 |
0.0008 |
| 95 |
HYPERPHAGIA |
3 |
0.0008 |
| 96 |
HALLUCINATIONS, MIXED |
3 |
0.0007 |
| 97 |
CULTURE URINE POSITIVE |
1 |
0.0007 |
| 98 |
INJECTION SITE HYPOAESTHESIA |
1 |
0.0007 |
| 99 |
NOROVIRUS INFECTION |
1 |
0.0007 |
| 100 |
SLEEP PARALYSIS |
1 |
0.0007 |
| 101 |
IMPETIGO |
1 |
0.0007 |
| 102 |
INFECTIOUS PLEURAL EFFUSION |
1 |
0.0007 |
| 103 |
ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0007 |
| 104 |
VIOLENCE-RELATED SYMPTOM |
1 |
0.0006 |
| 105 |
NEOPLASM SKIN |
1 |
0.0006 |
| 106 |
SUBSTANCE USE |
1 |
0.0006 |
| 107 |
INCREASED APPETITE |
12 |
0.0006 |
| 108 |
SHOULDER FRACTURE |
1 |
0.0006 |
| 109 |
MEDICAL PROCEDURE |
1 |
0.0006 |
| 110 |
EROSIVE OESOPHAGITIS |
1 |
0.0006 |
| 111 |
SEIZURE LIKE PHENOMENA |
1 |
0.0006 |
| 112 |
PRIAPISM |
2 |
0.0006 |
| 113 |
HYPOPITUITARISM |
1 |
0.0006 |
| 114 |
INTRA-ABDOMINAL FLUID COLLECTION |
1 |
0.0006 |
| 115 |
HYPERSEXUALITY |
1 |
0.0005 |
| 116 |
SUSPECTED PRODUCT QUALITY ISSUE |
1 |
0.0005 |
| 117 |
SINUS NODE DYSFUNCTION |
1 |
0.0005 |
| 118 |
SKIN DISCOLOURATION |
25 |
0.0005 |
| 119 |
NARCOLEPSY |
1 |
0.0005 |
| 120 |
MENOMETRORRHAGIA |
1 |
0.0005 |
| 121 |
THYROID MASS |
2 |
0.0005 |
| 122 |
RHEUMATIC DISORDER |
1 |
0.0005 |
| 123 |
EARLY SATIETY |
1 |
0.0005 |
| 124 |
DEREALISATION |
1 |
0.0005 |
| 125 |
GASTRIC BYPASS |
1 |
0.0005 |
| 126 |
PRODUCT PREPARATION ISSUE |
3 |
0.0005 |
| 127 |
DISCOURAGEMENT |
1 |
0.0004 |
| 128 |
HYPERNATRAEMIA |
2 |
0.0004 |
| 129 |
FLUID INTAKE REDUCED |
2 |
0.0004 |
| 130 |
TONSILLITIS |
2 |
0.0004 |
| 131 |
PERSONALITY DISORDER |
1 |
0.0004 |
| 132 |
ORAL FUNGAL INFECTION |
1 |
0.0004 |
| 133 |
HYPOMENORRHOEA |
1 |
0.0004 |
| 134 |
INJECTION SITE SCAR |
1 |
0.0004 |
| 135 |
SOCIAL AVOIDANT BEHAVIOUR |
2 |
0.0003 |
| 136 |
GROWTH RETARDATION |
1 |
0.0003 |
| 137 |
CEREBROVASCULAR DISORDER |
1 |
0.0003 |
| 138 |
PIGMENTATION DISORDER |
2 |
0.0003 |
| 139 |
INTENTIONAL DOSE OMISSION |
9 |
0.0003 |
| 140 |
INJECTION SITE IRRITATION |
4 |
0.0003 |
| 141 |
REFUSAL OF TREATMENT BY PATIENT |
2 |
0.0003 |
| 142 |
INITIAL INSOMNIA |
3 |
0.0003 |
| 143 |
REGURGITATION |
1 |
0.0003 |
| 144 |
CERVICAL VERTEBRAL FRACTURE |
1 |
0.0003 |
| 145 |
HYPOPHAGIA |
7 |
0.0003 |
| 146 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
1 |
0.0003 |
| 147 |
RHINOVIRUS INFECTION |
1 |
0.0003 |
| 148 |
MUSCLE RUPTURE |
1 |
0.0003 |
| 149 |
NAIL DISCOLOURATION |
1 |
0.0003 |
| 150 |
ENURESIS |
1 |
0.0002 |
| 151 |
ADRENAL INSUFFICIENCY |
3 |
0.0002 |
| 152 |
PRODUCT DOSE OMISSION IN ERROR |
7 |
0.0002 |
| 153 |
SOCIAL PROBLEM |
1 |
0.0002 |
| 154 |
THYROID FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 155 |
ERECTION INCREASED |
1 |
0.0002 |
| 156 |
SELF-INJURIOUS IDEATION |
1 |
0.0002 |
| 157 |
MUSCLE FATIGUE |
1 |
0.0002 |
| 158 |
TEARFULNESS |
1 |
0.0002 |
| 159 |
TONGUE DISCOLOURATION |
1 |
0.0002 |
| 160 |
INJECTION SITE PRURITUS |
15 |
0.0002 |
| 161 |
THERAPY INTERRUPTED |
16 |
0.0002 |
| 162 |
BLOOD PRESSURE DIASTOLIC INCREASED |
1 |
0.0002 |
| 163 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 164 |
SUBCUTANEOUS ABSCESS |
1 |
0.0002 |
| 165 |
PARAESTHESIA ORAL |
3 |
0.0002 |
| 166 |
AFFECT LABILITY |
2 |
0.0002 |
| 167 |
PHARYNGEAL SWELLING |
2 |
0.0002 |
| 168 |
INJECTION SITE URTICARIA |
5 |
0.0002 |
| 169 |
INJECTION SITE INFLAMMATION |
1 |
0.0002 |
| 170 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 171 |
ERYSIPELAS |
1 |
0.0002 |
| 172 |
WEIGHT FLUCTUATION |
2 |
0.0002 |
| 173 |
PARTIAL SEIZURES |
1 |
0.0002 |
| 174 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 175 |
HIP SURGERY |
1 |
0.0002 |
| 176 |
FAECALOMA |
1 |
0.0002 |
| 177 |
INTERMENSTRUAL BLEEDING |
1 |
0.0002 |
| 178 |
STATUS EPILEPTICUS |
2 |
0.0002 |
| 179 |
HYPERVENTILATION |
1 |
0.0002 |
| 180 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 181 |
HYPERTRIGLYCERIDAEMIA |
1 |
0.0002 |
| 182 |
THIRST |
3 |
0.0002 |
| 183 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0002 |
| 184 |
SCOLIOSIS |
1 |
0.0002 |
| 185 |
AGGRESSION |
8 |
0.0002 |
| 186 |
INCOHERENT |
1 |
0.0002 |
| 187 |
INJECTION SITE INDURATION |
2 |
0.0002 |
| 188 |
SKIN MASS |
1 |
0.0001 |
| 189 |
BREAST MASS |
1 |
0.0001 |
| 190 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 191 |
SINUS CONGESTION |
2 |
0.0001 |
| 192 |
ANGER |
5 |
0.0001 |
| 193 |
GENERAL PHYSICAL CONDITION ABNORMAL |
1 |
0.0001 |
| 194 |
ABNORMAL LOSS OF WEIGHT |
1 |
0.0001 |
| 195 |
BLOOD TESTOSTERONE DECREASED |
1 |
0.0001 |
| 196 |
LYMPHOEDEMA |
1 |
0.0001 |
| 197 |
AUTOIMMUNE HEPATITIS |
1 |
0.0001 |
| 198 |
FEAR OF INJECTION |
1 |
0.0001 |
| 199 |
FAECES SOFT |
1 |
0.0001 |
| 200 |
APATHY |
2 |
0.0001 |
| 201 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 202 |
DEPRESSED MOOD |
7 |
0.0001 |
| 203 |
LIPASE INCREASED |
1 |
0.0001 |
| 204 |
ANKLE FRACTURE |
2 |
0.0001 |
| 205 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 206 |
RENAL CYST |
1 |
0.0001 |
| 207 |
INJECTION SITE BRUISING |
10 |
0.0001 |
| 208 |
MUSCLE DISORDER |
1 |
0.0001 |
| 209 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 210 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 211 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 212 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 213 |
ANURIA |
1 |
0.0001 |
| 214 |
MENTAL DISORDER |
5 |
0.0001 |
| 215 |
INJECTION SITE ERYTHEMA |
14 |
0.0001 |
| 216 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 217 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 218 |
FLANK PAIN |
1 |
0.0001 |
| 219 |
PHOTOPHOBIA |
2 |
0.0001 |
| 220 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 221 |
INTENTIONAL SELF-INJURY |
2 |
0.0001 |
| 222 |
HYPOTHERMIA |
1 |
0.0001 |
| 223 |
ILLNESS |
10 |
0.0001 |
| 224 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 225 |
INCONTINENCE |
1 |
0.0001 |
| 226 |
MOOD SWINGS |
3 |
0.0001 |
| 227 |
RETCHING |
2 |
0.0001 |
| 228 |
WEIGHT INCREASED |
21 |
0.0001 |
| 229 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 230 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 231 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 232 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 233 |
MALNUTRITION |
1 |
0.0001 |
| 234 |
SKIN INFECTION |
1 |
0.0001 |
| 235 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 236 |
CHROMATURIA |
2 |
0.0001 |
| 237 |
SUICIDAL IDEATION |
8 |
0.0001 |
| 238 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 239 |
HYPOXIA |
3 |
0.0001 |
| 240 |
BACTERAEMIA |
1 |
0.0001 |
| 241 |
MYOCLONUS |
1 |
0.0001 |
| 242 |
CRYING |
3 |
0.0001 |
| 243 |
HYPOGLYCAEMIA |
4 |
0.0001 |
| 244 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 245 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 246 |
INJECTION SITE MASS |
3 |
0.0001 |
| 247 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 248 |
PHARYNGITIS |
1 |
0.0001 |
| 249 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 250 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 251 |
INTRAOCULAR PRESSURE INCREASED |
1 |
0.0001 |
| 252 |
HOSPITALISATION |
12 |
0.0001 |
| 253 |
NODULE |
1 |
0.0001 |
| 254 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 255 |
ABNORMAL BEHAVIOUR |
3 |
0.0001 |
| 256 |
ADVERSE REACTION |
1 |
0.0001 |
| 257 |
EAR INFECTION |
2 |
0.0001 |
| 258 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 259 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 260 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 261 |
TREATMENT NONCOMPLIANCE |
4 |
0.0001 |
| 262 |
FEELING COLD |
2 |
0.0001 |
| 263 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 264 |
APHONIA |
1 |
0.0001 |
| 265 |
HYPONATRAEMIA |
4 |
0.0001 |
| 266 |
SKIN REACTION |
1 |
0.0001 |
| 267 |
SLEEP DISORDER |
5 |
0.0001 |
| 268 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 269 |
BRONCHOSPASM |
1 |
0.0001 |
| 270 |
DECREASED APPETITE |
16 |
0.0001 |
| 271 |
GASTROENTERITIS |
1 |
0.0001 |
| 272 |
SURGERY |
4 |
0.0001 |
| 273 |
NAUSEA |
54 |
0.0001 |
| 274 |
AGITATION |
5 |
0.0001 |
| 275 |
THERAPEUTIC RESPONSE UNEXPECTED |
3 |
0.0001 |
| 276 |
BLOOD POTASSIUM DECREASED |
2 |
0.0001 |
| 277 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 278 |
OFF LABEL USE |
58 |
0.0001 |
| 279 |
EPILEPSY |
2 |
0.0001 |
| 280 |
INJECTION SITE SWELLING |
5 |
0.0001 |
| 281 |
FEELING HOT |
4 |
0.0001 |
| 282 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 283 |
THYROID DISORDER |
1 |
0.0001 |
| 284 |
DELUSION |
1 |
0.0001 |
| 285 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 286 |
VOMITING |
30 |
0.0001 |
| 287 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 288 |
DRUG INTOLERANCE |
6 |
0.0001 |
| 289 |
CHOLELITHIASIS |
2 |
0.0001 |
| 290 |
MANIA |
1 |
0.0001 |
| 291 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 292 |
ABDOMINAL PAIN |
14 |
0.0001 |
| 293 |
URINARY RETENTION |
2 |
0.0001 |
| 294 |
PERICARDITIS |
1 |
0.0001 |
| 295 |
HEMIPARESIS |
1 |
0.0001 |
| 296 |
FLUID RETENTION |
3 |
0.0001 |
| 297 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 298 |
SCAR |
1 |
0.0001 |
| 299 |
ABDOMINAL PAIN UPPER |
12 |
0.0001 |
| 300 |
INJECTION SITE REACTION |
4 |
0.0001 |
| 301 |
PARANOIA |
1 |
0.0001 |
| 302 |
PRODUCT DOSE OMISSION ISSUE |
17 |
0.0001 |
| 303 |
SYRINGE ISSUE |
1 |
0.0001 |
| 304 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 305 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 306 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 307 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 308 |
GASTROINTESTINAL DISORDER |
5 |
0.0001 |
| 309 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 310 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 311 |
RESTLESSNESS |
2 |
0.0001 |
| 312 |
SOMNOLENCE |
11 |
0.0001 |
| 313 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 314 |
THINKING ABNORMAL |
1 |
0.0001 |
| 315 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 316 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 317 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 318 |
HERNIA |
1 |
0.0001 |
| 319 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 320 |
SINUS DISORDER |
1 |
0.0001 |
| 321 |
SYNCOPE |
5 |
0.0000 |
| 322 |
FEEDING DISORDER |
1 |
0.0000 |
| 323 |
DISCOMFORT |
3 |
0.0000 |
| 324 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 325 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 326 |
HEADACHE |
30 |
0.0000 |
| 327 |
EATING DISORDER |
1 |
0.0000 |
| 328 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 329 |
SKIN CANCER |
1 |
0.0000 |
| 330 |
INFLUENZA |
5 |
0.0000 |
| 331 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 332 |
SNEEZING |
1 |
0.0000 |
| 333 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
8 |
0.0000 |
| 334 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 335 |
HYPOKALAEMIA |
2 |
0.0000 |
| 336 |
SEIZURE |
5 |
0.0000 |
| 337 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 338 |
DYSPHAGIA |
4 |
0.0000 |
| 339 |
ABDOMINAL DISCOMFORT |
7 |
0.0000 |
| 340 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 341 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 342 |
LUNG DISORDER |
2 |
0.0000 |
| 343 |
LIVER INJURY |
1 |
0.0000 |
| 344 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 345 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 346 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 347 |
HEPATITIS |
1 |
0.0000 |
| 348 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 349 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 350 |
MUSCLE SPASMS |
7 |
0.0000 |
| 351 |
JOINT STIFFNESS |
1 |
0.0000 |
| 352 |
GASTRITIS |
1 |
0.0000 |
| 353 |
PANCREATITIS |
2 |
0.0000 |
| 354 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 355 |
JAUNDICE |
1 |
0.0000 |
| 356 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 357 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 358 |
PNEUMONITIS |
1 |
0.0000 |
| 359 |
CONSTIPATION |
8 |
0.0000 |
| 360 |
MOOD ALTERED |
1 |
0.0000 |
| 361 |
SKIN LESION |
1 |
0.0000 |
| 362 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 363 |
INJECTION SITE PAIN |
11 |
0.0000 |
| 364 |
RENAL IMPAIRMENT |
3 |
0.0000 |
| 365 |
FLATULENCE |
2 |
0.0000 |
| 366 |
DEPRESSION |
8 |
0.0000 |
| 367 |
ANGINA PECTORIS |
1 |
0.0000 |
| 368 |
HYPERSOMNIA |
1 |
0.0000 |
| 369 |
ASTHENIA |
13 |
0.0000 |
| 370 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 371 |
PALPITATIONS |
4 |
0.0000 |
| 372 |
CHILLS |
4 |
0.0000 |
| 373 |
INSOMNIA |
9 |
0.0000 |
| 374 |
TACHYCARDIA |
3 |
0.0000 |
| 375 |
IRRITABILITY |
2 |
0.0000 |
| 376 |
HEPATIC FAILURE |
1 |
0.0000 |
| 377 |
APHASIA |
1 |
0.0000 |
| 378 |
INJECTION SITE RASH |
1 |
0.0000 |
| 379 |
NASOPHARYNGITIS |
6 |
0.0000 |
| 380 |
DIARRHOEA |
21 |
0.0000 |
| 381 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 382 |
PRODUCT USE IN UNAPPROVED INDICATION |
8 |
0.0000 |
| 383 |
HEAD INJURY |
1 |
0.0000 |
| 384 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 385 |
RHINORRHOEA |
2 |
0.0000 |
| 386 |
FATIGUE |
24 |
0.0000 |
| 387 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 388 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 389 |
VIRAL INFECTION |
1 |
0.0000 |
| 390 |
EYE PRURITUS |
1 |
0.0000 |
| 391 |
MALAISE |
13 |
0.0000 |
| 392 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 393 |
FLUSHING |
3 |
0.0000 |
| 394 |
DELIRIUM |
1 |
0.0000 |
| 395 |
HEART RATE DECREASED |
1 |
0.0000 |
| 396 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 397 |
DIZZINESS |
14 |
0.0000 |
| 398 |
PANIC ATTACK |
1 |
0.0000 |
| 399 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 400 |
BRONCHITIS |
2 |
0.0000 |
| 401 |
HYPERSENSITIVITY |
5 |
0.0000 |
| 402 |
EYE SWELLING |
1 |
0.0000 |
| 403 |
EPISTAXIS |
2 |
0.0000 |
| 404 |
DYSARTHRIA |
1 |
0.0000 |
| 405 |
ASTHMA |
3 |
0.0000 |
| 406 |
HOT FLUSH |
2 |
0.0000 |
| 407 |
INCORRECT DOSE ADMINISTERED |
6 |
0.0000 |
| 408 |
COUGH |
7 |
0.0000 |
| 409 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 410 |
HYPOTENSION |
5 |
0.0000 |
| 411 |
DRY MOUTH |
2 |
0.0000 |
| 412 |
BLINDNESS |
1 |
0.0000 |
| 413 |
POLLAKIURIA |
1 |
0.0000 |
| 414 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 415 |
MYALGIA |
4 |
0.0000 |
| 416 |
PYREXIA |
8 |
0.0000 |
| 417 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 418 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 419 |
DEHYDRATION |
3 |
0.0000 |
| 420 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 421 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 422 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 423 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 424 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 425 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 426 |
CHEST PAIN |
4 |
0.0000 |
| 427 |
BACK PAIN |
5 |
0.0000 |
| 428 |
WEIGHT DECREASED |
6 |
0.0000 |
| 429 |
PRODUCT USE ISSUE |
4 |
0.0000 |
| 430 |
FALL |
7 |
0.0000 |
| 431 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 432 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 433 |
DYSPEPSIA |
2 |
0.0000 |
| 434 |
HEART RATE INCREASED |
2 |
0.0000 |
| 435 |
HYPOAESTHESIA |
3 |
0.0000 |
| 436 |
CELLULITIS |
1 |
0.0000 |
| 437 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 438 |
THERAPY CESSATION |
1 |
0.0000 |
| 439 |
ERYTHEMA |
4 |
0.0000 |
| 440 |
INFLAMMATION |
1 |
0.0000 |
| 441 |
ARTHRALGIA |
8 |
0.0000 |
| 442 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 443 |
ECZEMA |
1 |
0.0000 |
| 444 |
SPEECH DISORDER |
1 |
0.0000 |
| 445 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 446 |
OVERDOSE |
4 |
0.0000 |
| 447 |
RASH PRURITIC |
1 |
0.0000 |
| 448 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 449 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 450 |
ARTHROPATHY |
1 |
0.0000 |
| 451 |
MEDICATION ERROR |
1 |
0.0000 |
| 452 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 453 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 454 |
ANXIETY |
5 |
0.0000 |
| 455 |
BONE PAIN |
1 |
0.0000 |
| 456 |
NASAL CONGESTION |
1 |
0.0000 |
| 457 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 458 |
FEELING ABNORMAL |
4 |
0.0000 |
| 459 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 460 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 461 |
ANAEMIA |
3 |
0.0000 |
| 462 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 463 |
PNEUMONIA |
5 |
0.0000 |
| 464 |
SWELLING FACE |
1 |
0.0000 |
| 465 |
ALOPECIA |
3 |
0.0000 |
| 466 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 467 |
INJURY |
1 |
0.0000 |
| 468 |
INFECTION |
2 |
0.0000 |
| 469 |
UNDERDOSE |
1 |
0.0000 |
| 470 |
DYSGEUSIA |
1 |
0.0000 |
| 471 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 472 |
PRURITUS |
5 |
0.0000 |
| 473 |
ARTHRITIS |
1 |
0.0000 |
| 474 |
DRUG INTERACTION |
2 |
0.0000 |
| 475 |
CARDIAC FAILURE |
1 |
0.0000 |
| 476 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 477 |
CARDIAC ARREST |
1 |
0.0000 |
| 478 |
TREMOR |
2 |
0.0000 |
| 479 |
URTICARIA |
2 |
0.0000 |
| 480 |
BALANCE DISORDER |
1 |
0.0000 |
| 481 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 482 |
COVID-19 |
2 |
0.0000 |
| 483 |
PAIN |
7 |
0.0000 |
| 484 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 485 |
ADVERSE EVENT |
1 |
0.0000 |
| 486 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 487 |
CARDIAC DISORDER |
1 |
0.0000 |
| 488 |
DYSPNOEA |
6 |
0.0000 |
| 489 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 490 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 491 |
MIGRAINE |
1 |
0.0000 |
| 492 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 493 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 494 |
DRUG INEFFECTIVE |
13 |
0.0000 |
| 495 |
SINUSITIS |
1 |
0.0000 |
| 496 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 497 |
SEPSIS |
1 |
0.0000 |
| 498 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 499 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 500 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 501 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 502 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 503 |
HYPERHIDROSIS |
1 |
0.0000 |
| 504 |
PSORIASIS |
1 |
0.0000 |
| 505 |
RENAL FAILURE |
1 |
0.0000 |
| 506 |
DRY SKIN |
1 |
0.0000 |
| 507 |
VISION BLURRED |
1 |
0.0000 |
| 508 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 509 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 510 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 511 |
PARAESTHESIA |
1 |
0.0000 |
| 512 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 513 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 514 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 515 |
HYPERTENSION |
1 |
0.0000 |
| 516 |
RASH |
2 |
0.0000 |
| 517 |
DEATH |
2 |
0.0000 |